Medical Devices & Consumables

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bacterial Enteric Disease Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Becton Dickinson & Company
Bio-Rad Laboratories, Inc
Biomerieux SA
Quest Diagnostics Inc
Diasorin S.p.A.
Meridian Bioscience Inc
Abbott Laboratories
Trinity Biotech
Coris BioConcept
Biomerica, Inc.
Cepheid
Segment by Type
Reagents and Consumables
Equipment
Segment by Application
Academic and Research Institutes
Hospital Laboratories
Pharmaceutical and Biotechnology Companies
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Bacterial Enteric Disease Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Bacterial Enteric Disease Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bacterial Enteric Disease Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Reagents and Consumables
1.2.3 Equipment
1.3 Market Segmentation by Application
1.3.1 Global Bacterial Enteric Disease Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic and Research Institutes
1.3.3 Hospital Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bacterial Enteric Disease Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Bacterial Enteric Disease Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bacterial Enteric Disease Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bacterial Enteric Disease Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Reagents and Consumables Market Size by Players
3.3.2 Equipment Market Size by Players
3.4 Global Bacterial Enteric Disease Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bacterial Enteric Disease Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bacterial Enteric Disease Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bacterial Enteric Disease Testing Market Size by Type (2020-2031)
6.4 North America Bacterial Enteric Disease Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bacterial Enteric Disease Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bacterial Enteric Disease Testing Market Size by Type (2020-2031)
7.4 Europe Bacterial Enteric Disease Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bacterial Enteric Disease Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bacterial Enteric Disease Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Bacterial Enteric Disease Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bacterial Enteric Disease Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bacterial Enteric Disease Testing Market Size by Type (2020-2031)
9.4 Central and South America Bacterial Enteric Disease Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bacterial Enteric Disease Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bacterial Enteric Disease Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Bacterial Enteric Disease Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bacterial Enteric Disease Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Corporation Information
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Bacterial Enteric Disease Testing Product Features and Attributes
11.1.4 Becton Dickinson & Company Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.1.5 Becton Dickinson & Company Bacterial Enteric Disease Testing Revenue by Product in 2024
11.1.6 Becton Dickinson & Company Bacterial Enteric Disease Testing Revenue by Application in 2024
11.1.7 Becton Dickinson & Company Bacterial Enteric Disease Testing Revenue by Geographic Area in 2024
11.1.8 Becton Dickinson & Company Bacterial Enteric Disease Testing SWOT Analysis
11.1.9 Becton Dickinson & Company Recent Developments
11.2 Bio-Rad Laboratories, Inc
11.2.1 Bio-Rad Laboratories, Inc Corporation Information
11.2.2 Bio-Rad Laboratories, Inc Business Overview
11.2.3 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing Product Features and Attributes
11.2.4 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.2.5 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing Revenue by Product in 2024
11.2.6 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing Revenue by Application in 2024
11.2.7 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing Revenue by Geographic Area in 2024
11.2.8 Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing SWOT Analysis
11.2.9 Bio-Rad Laboratories, Inc Recent Developments
11.3 Biomerieux SA
11.3.1 Biomerieux SA Corporation Information
11.3.2 Biomerieux SA Business Overview
11.3.3 Biomerieux SA Bacterial Enteric Disease Testing Product Features and Attributes
11.3.4 Biomerieux SA Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.3.5 Biomerieux SA Bacterial Enteric Disease Testing Revenue by Product in 2024
11.3.6 Biomerieux SA Bacterial Enteric Disease Testing Revenue by Application in 2024
11.3.7 Biomerieux SA Bacterial Enteric Disease Testing Revenue by Geographic Area in 2024
11.3.8 Biomerieux SA Bacterial Enteric Disease Testing SWOT Analysis
11.3.9 Biomerieux SA Recent Developments
11.4 Quest Diagnostics Inc
11.4.1 Quest Diagnostics Inc Corporation Information
11.4.2 Quest Diagnostics Inc Business Overview
11.4.3 Quest Diagnostics Inc Bacterial Enteric Disease Testing Product Features and Attributes
11.4.4 Quest Diagnostics Inc Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.4.5 Quest Diagnostics Inc Bacterial Enteric Disease Testing Revenue by Product in 2024
11.4.6 Quest Diagnostics Inc Bacterial Enteric Disease Testing Revenue by Application in 2024
11.4.7 Quest Diagnostics Inc Bacterial Enteric Disease Testing Revenue by Geographic Area in 2024
11.4.8 Quest Diagnostics Inc Bacterial Enteric Disease Testing SWOT Analysis
11.4.9 Quest Diagnostics Inc Recent Developments
11.5 Diasorin S.p.A.
11.5.1 Diasorin S.p.A. Corporation Information
11.5.2 Diasorin S.p.A. Business Overview
11.5.3 Diasorin S.p.A. Bacterial Enteric Disease Testing Product Features and Attributes
11.5.4 Diasorin S.p.A. Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.5.5 Diasorin S.p.A. Bacterial Enteric Disease Testing Revenue by Product in 2024
11.5.6 Diasorin S.p.A. Bacterial Enteric Disease Testing Revenue by Application in 2024
11.5.7 Diasorin S.p.A. Bacterial Enteric Disease Testing Revenue by Geographic Area in 2024
11.5.8 Diasorin S.p.A. Bacterial Enteric Disease Testing SWOT Analysis
11.5.9 Diasorin S.p.A. Recent Developments
11.6 Meridian Bioscience Inc
11.6.1 Meridian Bioscience Inc Corporation Information
11.6.2 Meridian Bioscience Inc Business Overview
11.6.3 Meridian Bioscience Inc Bacterial Enteric Disease Testing Product Features and Attributes
11.6.4 Meridian Bioscience Inc Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.6.5 Meridian Bioscience Inc Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Bacterial Enteric Disease Testing Product Features and Attributes
11.7.4 Abbott Laboratories Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.7.5 Abbott Laboratories Recent Developments
11.8 Trinity Biotech
11.8.1 Trinity Biotech Corporation Information
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Bacterial Enteric Disease Testing Product Features and Attributes
11.8.4 Trinity Biotech Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.8.5 Trinity Biotech Recent Developments
11.9 Coris BioConcept
11.9.1 Coris BioConcept Corporation Information
11.9.2 Coris BioConcept Business Overview
11.9.3 Coris BioConcept Bacterial Enteric Disease Testing Product Features and Attributes
11.9.4 Coris BioConcept Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.9.5 Coris BioConcept Recent Developments
11.10 Biomerica, Inc.
11.10.1 Biomerica, Inc. Corporation Information
11.10.2 Biomerica, Inc. Business Overview
11.10.3 Biomerica, Inc. Bacterial Enteric Disease Testing Product Features and Attributes
11.10.4 Biomerica, Inc. Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Cepheid
11.11.1 Cepheid Corporation Information
11.11.2 Cepheid Business Overview
11.11.3 Cepheid Bacterial Enteric Disease Testing Product Features and Attributes
11.11.4 Cepheid Bacterial Enteric Disease Testing Revenue and Gross Margin (2020-2025)
11.11.5 Cepheid Recent Developments
12 Bacterial Enteric Disease TestingIndustry Chain Analysis
12.1 Bacterial Enteric Disease Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bacterial Enteric Disease Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bacterial Enteric Disease Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bacterial Enteric Disease Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bacterial Enteric Disease Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Bacterial Enteric Disease Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Bacterial Enteric Disease Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Bacterial Enteric Disease Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Enteric Disease Testing as of 2024)
Table 11. Global Bacterial Enteric Disease Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Bacterial Enteric Disease Testing Companies Headquarters
Table 13. Global Bacterial Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Bacterial Enteric Disease Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Bacterial Enteric Disease Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Bacterial Enteric Disease Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Bacterial Enteric Disease Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Bacterial Enteric Disease Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 25. North America Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 27. Europe Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Bacterial Enteric Disease Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Bacterial Enteric Disease Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Bacterial Enteric Disease Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Bacterial Enteric Disease Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Becton Dickinson & Company Corporation Information
Table 35. Becton Dickinson & Company Description and Major Businesses
Table 36. Becton Dickinson & Company Product Features and Attributes
Table 37. Becton Dickinson & Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Becton Dickinson & Company Revenue Proportion by Product in 2024
Table 39. Becton Dickinson & Company Revenue Proportion by Application in 2024
Table 40. Becton Dickinson & Company Revenue Proportion by Geographic Area in 2024
Table 41. Becton Dickinson & Company Bacterial Enteric Disease Testing SWOT Analysis
Table 42. Becton Dickinson & Company Recent Developments
Table 43. Bio-Rad Laboratories, Inc Corporation Information
Table 44. Bio-Rad Laboratories, Inc Description and Major Businesses
Table 45. Bio-Rad Laboratories, Inc Product Features and Attributes
Table 46. Bio-Rad Laboratories, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Bio-Rad Laboratories, Inc Revenue Proportion by Product in 2024
Table 48. Bio-Rad Laboratories, Inc Revenue Proportion by Application in 2024
Table 49. Bio-Rad Laboratories, Inc Revenue Proportion by Geographic Area in 2024
Table 50. Bio-Rad Laboratories, Inc Bacterial Enteric Disease Testing SWOT Analysis
Table 51. Bio-Rad Laboratories, Inc Recent Developments
Table 52. Biomerieux SA Corporation Information
Table 53. Biomerieux SA Description and Major Businesses
Table 54. Biomerieux SA Product Features and Attributes
Table 55. Biomerieux SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Biomerieux SA Revenue Proportion by Product in 2024
Table 57. Biomerieux SA Revenue Proportion by Application in 2024
Table 58. Biomerieux SA Revenue Proportion by Geographic Area in 2024
Table 59. Biomerieux SA Bacterial Enteric Disease Testing SWOT Analysis
Table 60. Biomerieux SA Recent Developments
Table 61. Quest Diagnostics Inc Corporation Information
Table 62. Quest Diagnostics Inc Description and Major Businesses
Table 63. Quest Diagnostics Inc Product Features and Attributes
Table 64. Quest Diagnostics Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Quest Diagnostics Inc Revenue Proportion by Product in 2024
Table 66. Quest Diagnostics Inc Revenue Proportion by Application in 2024
Table 67. Quest Diagnostics Inc Revenue Proportion by Geographic Area in 2024
Table 68. Quest Diagnostics Inc Bacterial Enteric Disease Testing SWOT Analysis
Table 69. Quest Diagnostics Inc Recent Developments
Table 70. Diasorin S.p.A. Corporation Information
Table 71. Diasorin S.p.A. Description and Major Businesses
Table 72. Diasorin S.p.A. Product Features and Attributes
Table 73. Diasorin S.p.A. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Diasorin S.p.A. Revenue Proportion by Product in 2024
Table 75. Diasorin S.p.A. Revenue Proportion by Application in 2024
Table 76. Diasorin S.p.A. Revenue Proportion by Geographic Area in 2024
Table 77. Diasorin S.p.A. Bacterial Enteric Disease Testing SWOT Analysis
Table 78. Diasorin S.p.A. Recent Developments
Table 79. Meridian Bioscience Inc Corporation Information
Table 80. Meridian Bioscience Inc Description and Major Businesses
Table 81. Meridian Bioscience Inc Product Features and Attributes
Table 82. Meridian Bioscience Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Meridian Bioscience Inc Recent Developments
Table 84. Abbott Laboratories Corporation Information
Table 85. Abbott Laboratories Description and Major Businesses
Table 86. Abbott Laboratories Product Features and Attributes
Table 87. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Recent Developments
Table 89. Trinity Biotech Corporation Information
Table 90. Trinity Biotech Description and Major Businesses
Table 91. Trinity Biotech Product Features and Attributes
Table 92. Trinity Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Trinity Biotech Recent Developments
Table 94. Coris BioConcept Corporation Information
Table 95. Coris BioConcept Description and Major Businesses
Table 96. Coris BioConcept Product Features and Attributes
Table 97. Coris BioConcept Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Coris BioConcept Recent Developments
Table 99. Biomerica, Inc. Corporation Information
Table 100. Biomerica, Inc. Description and Major Businesses
Table 101. Biomerica, Inc. Product Features and Attributes
Table 102. Biomerica, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biomerica, Inc. Recent Developments
Table 104. Cepheid Corporation Information
Table 105. Cepheid Description and Major Businesses
Table 106. Cepheid Product Features and Attributes
Table 107. Cepheid Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Cepheid Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources


List of Figures
Figure 1. Bacterial Enteric Disease Testing Product Picture
Figure 2. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Reagents and Consumables Product Picture
Figure 4. Equipment Product Picture
Figure 5. Global Bacterial Enteric Disease Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Academic and Research Institutes
Figure 7. Hospital Laboratories
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Bacterial Enteric Disease Testing Report Years Considered
Figure 10. Global Bacterial Enteric Disease Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 12. Global Bacterial Enteric Disease Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Bacterial Enteric Disease Testing Revenue Market Share by Region (2020-2031)
Figure 14. Global Bacterial Enteric Disease Testing Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Reagents and Consumables Revenue Market Share by Player in 2024
Figure 17. Equipment Revenue Market Share by Player in 2024
Figure 18. Global Bacterial Enteric Disease Testing Revenue Market Share by Type (2020-2031)
Figure 19. Global Bacterial Enteric Disease Testing Revenue Market Share by Application (2020-2031)
Figure 20. North America Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 22. North America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 29. Europe Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 32. France Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 44. India Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Bacterial Enteric Disease Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 52. Central and South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Bacterial Enteric Disease Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Bacterial Enteric Disease Testing Revenue (US$ Million) in 2024
Figure 58. South America Bacterial Enteric Disease Testing Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Bacterial Enteric Disease Testing Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Bacterial Enteric Disease Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Bacterial Enteric Disease Testing Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies